Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS/TEN) are potentially life-threatening, immune-mediated adverse reactions characterized by widespread erythema, epidermal necrosis, and detachment of skin and mucosa. Efforts to grow and develop functional international collaborations and a multidisciplinary interactive network focusing on SJS/TEN as an uncommon but high burden disease will be necessary to improve efforts in prevention, early diagnosis and improved acute and long-term management. SJS/TEN 2019: From Science to Translation was a 1.5-day scientific program held April 26-27, 2019, in Vancouver, Canada. The meeting successfully engaged clinicians, researchers, and patients and conducted many productive discussions on research and patient care needs.
Keywords: Human leukocyte antigen (HLA); Pharmacogenomics; Pharmacovigilance; Severe cutaneous adverse reaction (SCAR); Stevens-Johnson syndrome (SJS); Toxic epidermal necrolysis (TEN).
Crown Copyright © 2020. Published by Elsevier B.V. All rights reserved.